Explore the complete record of transactions filed by Friedmann Nadav, Directeur. Officer active across 1 company, notably Cassava Sciences INC. Aggregated, 1 filings have been recorded. Activity tracked since 27 May 2022. The latest transaction was filed on 27 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Nadav Friedmann is the Chief Medical Officer at Cassava Sciences Inc. He oversees the medical and scientific aspects of the company's operations. His expertise in biology and medicine enables him to guide the development of new therapies and ensure their compliance with regulatory standards.